IHE is recruiting a leader to direct the ongoing Health Technology Innovation Platform (HTIP) and develop and manage additional public private partnership collaborations being established under the HTIP banner. HTIP is a public-private partnership between Health Canada, Canadian Agency for Drugs and Technologies in Health (CADTH), provincial drug plans (AB, BC, ON), and the pharmaceutical…
IHE is recruiting a Director of Health Technology Assessment to lead and grow our program of health evidence reviews conducted for provincial governments and health authorities, identify and develop new opportunities to provide HTA and evidence synthesis services with both the public and private sector, provide leadership on emerging and future challenges…
The Institute of Health Economics is recruiting a Senior Principal Health Economist / Senior Principal Modeler to provide leadership on projects in the health system portfolio of our health economics work. The successful candidate will contribute to the design and conduct of system level economic evaluations that cut across disease areas with a focus on interdependencies and dynamic…
11:00 a.m. – 12:00 p.m. MDT Dr. Mitchell is a Canada CIFAR AI Chair and the inaugural Alberta Health Services (AHS) Chair in AI in Health. He is a Professor in the Department of Medicine, and an Adjunct Professor in the Department of Computer Science at the University of Alberta. He is also a Fellow with the Alberta Machine Intelligence Institute…
The offices of the Institute of Health Economics will be closed on Monday, October 2nd, 2023 in observance of the National Day for Truth and Reconciliation. This is a day to “honour Survivors, their families, and communities, and ensure that public commemoration of the history and legacy of residential schools…
The Institute for Health Economics (IHE) presented a webinar on September 21, 2023, sharing an overview of a recent report: “Combination Regimens: Reimbursement Challenges and Solutions: Research Report and National Roundtable”. Combination therapy is the use of two or more therapies with the intention of…
New report highlights policy levers to support improvements in management of heart failure. The Institute for Health Economics (IHE) has published a report “Heart Failure Policy and Systems Evaluation: Research Report and National Canadian Roundtable”. The report, commissioned by Heartlife…
The institute of Health Economics congratulates our Director of Evidence Synthesis, Ken Bond, https://www.ihe.ca/about/staff-directory/ken-bond for his election to the Board of Directors for Health Technology Assessment International (HTAi) www.htai.org. HTAi is the preeminent global society for championing equitable, responsive and cutting edge health…
The IHE is pleased to have collaborated with global health industry leaders in the UNIVANTS of Healthcare Excellence awards in laboratory medicine and to share in announcement of the 2022 award winners. The UNIVANTS of Healthcare Excellence Award Program announces 11 teams from around the world for achieving measurably better healthcare performance www.UnivantsHCE.com. Foundational…
The Institute of Health Economics is pleased that the final version of the guidelines for the economic evaluation of vaccination programs in Canada were recently released by the National Advisory Committee on Immunization (NACI). The following IHE staff reviewed the draft guidelines and welcomed the opportunity to participate in the process: Kate Harback, Christopher McCabe (former…
The IHE announces new CEO, Dr. Kate Harback. After an extensive search the Institute of Health Economics (IHE) Board of Directors has appointed Dr. Katherine (Kate) Harback as the new CEO and Executive Director for the IHE. Dr. Harback brings to the position significant applied economic expertise, not only in health, but in transportation and other industries with a high degree…
An IHE article, “A Conceptual Framework for Life Cycle Health Technology Assessment”, has been selected as an Editor’s Choice for 2022 by the academic journal Value in Health. The article outlines how standard HTA processes sometimes struggle to (1) support decisions that involve significant uncertainty and (2) encourage continued generation of and adaptation to new evidence. Authors…
Canada’s Chief Science Advisor established a multidisciplinary task force in July 2022 to investigate and advise on ways to address post-COVID-19 condition in Canada. Dr. Ellen Rafferty from the Institute of Health Economics was invited to contribute to the report as a subject matter expert. Today, the taskforce…
On February 6th, the Faculty of Pharmacy and Pharmaceutical Sciences -Seminar Series Presents “The Role of Health Economics in Supporting Clinical and Health Services Research” Speaker: Dr. Jeff Round Chief Scientific Officer, Institute of Health Economics Professor of Health Economics, Department of Pediatrics, University of Alberta Date: Monday, February 6, 2023 Location: Hybrid…
The Institute of Health Economics’ Senior Policy Director John Sproule has received the Queen Elizabeth II Platinum Jubilee medal. John was nominated by the Alberta Ministry of Health and the following citation was given: “In recognition of his long and distinguished career focused on improving health outcomes in Alberta and Canada, and his tireless efforts to drive change and…
The IHE is pleased to receive support from Western Economic Diversification to help Life Sciences companies with promising market-ready innovations to make a stronger economic case for market access. The Institute of Health Economics (IHE) is receiving $953,250 in WD funding over three years to support approximately 30 western Canadian health companies with customized economic…
Established by the President of the Royal Society of Canada in April 2020, the RSC Task Force on COVID-19 was mandated to provide evidence-informed perspectives on major societal challenges in response to and recovery from COVID-19. The Task Force established a series of Working Groups to rapidly develop Policy Briefings, with the objective of supporting policy makers with evidence…
The Institute of Health Economics (IHE) is recruiting to support the Health Economics team's growing portfolio of work with government and non-profit research sponsors. We are seeking candidates with experience in economic modelling, to undertake work in the design and conduct of economic evaluations in health care. We would encourage any early and mid-level career professionals…
The Institute for Health Economics (IHE) is conducting an invitational, virtual policy roundtable on progressive fibrosing interstitial lung disease (PF-ILD) on November 20th, 2020. This policy roundtable will seek to gain multi-stakeholder consensus on policy recommendations intended to optimize care for PF-ILD patients Key areas for discuss are in the following three areas: Multi-disciplinary…
Dr. Chris McCabe, CEO of IHE, along with colleagues Dr. Richard Gold and Dr, Aled Edwards, discuss priorities to support economic recovery post-COVID-19 in an editorial in the November 30th, 2020 Globe and Mail. The priorities identified are 1) labour market transition; 2)…
The IHE is pleased to have collaborated with global health industry leaders in launching the UNIVANTS of Healthcare Excellence awards and to announce the 2020 award winners. The UNIVANTS of Healthcare Excellence Award Program has recently announced their 2020 winners. www.UnivantsHCE.com. The 2020 submissions included hospitals, commercial laboratories, reference laboratories,…
The Institute of Health Economics has two internship opportunities in our Health Economics and Industry Partnership Programs. The deadline for application is November 27th, 2020. These are made possible with support from BioTalent Canada www.biotalent.ca. Industry Partnerships – IHE Internship The focus of the internship project is on the economic evaluation of new health care…
The IHE Life Sciences Commercialization Program supports Alberta, Saskatchewan, Manitoba and British Columbia-based life sciences companies with promising, market-ready healthcare technology that are currently seeking procurement in Canadian or international markets. Support includes the development of an economic model to quantify the technology value…
The Institute of Health Economics has established the Health Technology Innovation Platform (HTIP): a three (3) year, $1.8 million collaboration supported by Boehringer Ingelheim, GlaxoSmithKline, and Roche Canada, which will explore new approaches for the assessment and adoption of innovative pharmaceuticals. (NOTE: additional partner…
EDMONTON, Alberta, Oct. 21, 2020 -- The health innovation community has one more approach towards increasing the timely and safe utilization of health data thanks to a research project co-sponsored by Health City and the Institute of Health Economics (IHE) in partnership with Alberta Innovates, Replica Analytics, and University of Alberta. Unique in Canada, this project was initiated…
News items are kept on the IHE website for 6 months. If you require an older news item, please contact us at [email protected].
For media inquiries, please contact John Sproule, Senior Policy Director at [email protected]
IHE Health Economist, Dr, Ellen Rafferty, discusses important considerations for COVID-19 vaccine distribution with Radio Canada on October 5, 2020. (see article link at bottom of page) “Decisions will need to be made very carefully and cooperatively…. (and) communications with the public will be important. People will need…
The IHE has a dedicated Life Sciences SME Platform within the Institute that collaborates with and provides support for SMEs in the life sciences. The IHE provides services to: educate SMEs and support organizations (e.g., accelerators) on the value and use of health economics to support decisions along the commercialization journey as well as procurement efforts; provide early-stage…
If you have any questions, please contact [email protected]. Email addresses for particular staff members can also be found at: https://www.ihe.ca/about/staff-directory. The Institute of Health Economics (IHE) is an independent, not-for-profit research organization that conducts health economics and health services research, performs health technology assessments, and convenes health…
Workshop Agenda
HTIP Health Economics Educational Workshop – Workshop Agenda Download Workshop Agenda
Workshop Brochure
HTIP Health Economics Educational Workshop – Workshop Brochure Download Workshop Brochure
23 November 2018 | 30 November 2018 Calgary, Alberta | Edmonton, Alberta 08:30 – 08:45 Introductions and Overview of IHE Mr. Dan PalfreyDownload Presentation 08:45 – 09:30 Case Study One Mr. Dan PalfreyDownload Presentation 09:30 – 10:15 Innovation Adoption in Alberta and Canada Dr. Christopher McCabeDownload Presentation 10:15 – 10:30 Break 10:30 – 11:30 Principles of Health Economics…
23 November 2018 | 30 November 2018 Calgary, Alberta | Edmonton, Alberta On November 23rd in Calgary and November 30th in Edmonton, the Institute of Health Economics (IHE) hosted an educational workshop designed to support both early and late stage organizations in developing an understanding of when, where, and how health economics can be used to strengthen product and business…
Sunday, 21 October 2018 Toronto, Ontario 09:00 – 09:15 Welcome and Design Sprint Overview Dr. Allan Gillman 09:15 – 10:15 Lightning Talks Ms. Rhonda KroppDownload Presentation Dr. Tammy Clifford and Dr. Trevor RichterDownload Presentation Dr. Kelvin ChanDownload Presentation Dr. Michael DuongDownload Presentation 10:15 – 10:30 Break 10:30 – 10:45 Design Challenge Statement and…
Summary Report Defining decision-grade real-world evidence and its role in the Canadian context: A design sprint – Summary report of a workshopDownload Summary Report (English) Définir les données probantes du monde réel utiles à la prise de décisions et leur rôle en contexte canadien: Un sprint de conception Rapport sommaire d’un atelier Téléchargez le rapport sommaire d’un atelier…
21 October 2018 Toronto, Ontario On October 21, 2018, Health Canada, the Canadian Agency for Drugs and Technologies in Health (CADTH), the Institute of Health Economics (IHE), and the Canadian Association for Population Therapeutics (CAPT) collaborated on Defining Decision-Grade Real-World Evidence and its Role in the Canadian Context: A Design Sprint. Held as a satellite to the…
Chief Medical Officer's Annual Report 2014-15 Chief Medical Officer's Annual Report 2014-15 – Realistic Medicinehttps://www.gov.scot/cmoannualreport201415 Chief Medical Officer's Annual Report 2015-16 Chief Medical Officer for Scotland Annual Report 2015/16 – Realising Realistic Medicinehttps://www.gov.scot/Publications/2017/02/3336 Chief Medical Officer's Annual Report 2016-17…
24 September 2018 Calgary, Alberta On September 24th, 2018 the Institute Health Economics (IHE) presented a roundtable at the BIO Alberta AGM and Conference. This Roundtable provided an overview of the IHE's education series for Alberta SMEs and ecosystem partners, and enabled participants to help define the content of the series so it would be most valuable to them. Beginning…
Health Technology Innovation Platform (HTIP) events are designed to support the HTIP initiative, by collaborating with and providing support for small- and medium-sized enterprises (SMEs) as well as multi-national enterprises (MNEs) in the life sciences. These events support the mission of the HTIP to enhance decision-making efficiency and improve value for money for purchasers…
14 September 2018 Edmonton, Alberta The Institute of Health Economics and The Network of Alberta Health Economists were pleased to present "Reflections on Balancing Academic and Policy Work," a mentorship and networking event for early career health economists (7 years or less from completion of PhD studies), with renown Health Economist, Dr. Karl Claxton, Professor of Economics,…
Speaker Biographies Keynote Speaker Dr. Catherine CalderwoodChief Medical Officer, Scotland Catherine Calderwood has been the Chief Medical Officer for Scotland since 2015. Catherine qualified from Cambridge and Glasgow Universities and continues to work as an obstetrician at a regular antenatal clinic at the Royal Infirmary of Edinburgh. She is responsible for the Health Promoting…
19 September 2018Edmonton, Alberta Welcome and Greetings WelcomeDr. Lorne TyrrellBoard Chair, IHE Greetings from the ProvinceMr. Justin RiemerAssistant Deputy Minister, Innovation and Strategic Operations Division, Alberta Healthhttps://vimeo.com/album/5450281/video/292002619 Keynote Presentations Realistic Medicine – Lessons from ScotlandDr. Catherine CalderwoodChief Medical Officer,…
19 September 2018Edmonton, Alberta Realistic Medicine - Trailer Realistic Medicine is the 18th IHE Innovation Forum, a semi-annual event bringing together senior public- and private-sector experts and decision-makers to address health care policy issues. Our 18th IHE Innovation Forum Keynote Speaker is Dr. Catherine Calderwood, Chief Medical Officer for the Scottish Government.…
Institute of Health Economics – Corporate Reports The Institute of Health Economics (IHE) is a not-for-profit organization funded through grants and commissioned work from public and private sector partners. The IHE is committed to transparency and accountability in the work we conduct. Key corporate reports which are completed and in development are outlined below. Strategic Plan:…
4 – 6 November 2014 Edmonton, Alberta The Institute of Health Economics, in collaboration with the Government of Alberta and with support from Alberta Health Services (AHS), hosted the Consensus Development Conference on Improving Mental Health Transitions in Edmonton, Alberta, from November 4 – 6, 2014. Download Consensus Statement | Télécharger la déclaration de consensus The…
How do you engage citizens, decision-makers, and experts in an appropriate way to address complex health issues? One approach is the Consensus Development Conference. The Consensus Development Conference approach has been used effectively in Alberta by the Institute of Health Economics. The program is modelled on the National Institute of Health (NIH) Consensus Development program…
Past Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. Events hosted or co-hosted by the IHE include the well-regarded Consensus Development Conference Series, which has seen us host international events on Fetal Alcohol Spectrum Disorder…
IHE Events The IHE serves as a neutral convenor for health policy dialogue and evidence development and dissemination. The format for each event is tailored to suit the topic, purpose, and audience. The IHE hosts various events of different sizes and audiences, on a wide variety of topics. Past events have included Health Policy events, the IHE Innovation Forum series, Roundtables,…
In addition to clinical data to demonstrate the safety and efficacy of a technology, life sciences small- and medium-sized enterprises (SMEs) require health economic data and analysis to demonstrate the cost-effectiveness of that technology for health systems, creating a comprehensive picture of how the technology is good value for money. Without this key component in an evidentiary…
Health Technology Innovation Platform HTIP is a public-private partnership between Health Canada, Canadian Agency for Drugs and Technologies in Health (CADTH), provincial drug plans (AB, BC, ON) and the innovative pharmaceutical industry including, Boehringer Ingelheim, GlaxoSmithKline, Roche Canada, Takeda Canada, and Novartis Pharmaceuticals Canada Inc. The HTIP goals include…
The goal of the Alberta Secondary Use Data Access (SUDA) initiative is to accelerate health research, support innovation, and strengthen the health system through insights from analysis of health data. The IHE is serving as a partner to the Government of Alberta (GOA) to strengthen analytic capacity and foster collaboration between the GOA, industry, and other contributors. The…
This clinical practice guideline and background document were produced as part of the Prairie Collaborative Immune Globulin (IG) Utilization Management Framework project, which was initiated to establish criteria for IG therapy as a means to increase accountability for the quality, safety, and sustainability of the blood supply system, and to demonstrate stewardship for the use…
Community Voices: Diabetes in Indigenous Populations is a video project that aims to highlight Indigenous perspectives on health, and promote shared learning for a variety of stakeholders within the context of health, well-being, and health care in Canada. New videos from the series will be added regularly, and will highlight voices from Indigenous communities describing current…
3 June 2018 Vancouver, British Columbia On June 3rd, as part of the 2018 Health Technology Assessment International (HTAi) Annual Conference in Vancouver, the Institute of Health Economics (IHE) led a panel presentation on facilitators, innovators, and innovations in chronic obstructive pulmonary disease (COPD) care in Canada. The panel, Facilitating Adoption of Innovative…
Program
Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making Forum – Final ProgramDownload Final Program
Selected References
Dr. Holroyd's Selected References – Low Value Care / Cognitive BiasesDownload Selected References
Thursday, 22 February 2018Edmonton, Alberta 13:00 – 13:15 Welcome from the IHE Dr. Chris McCabeCEO, Institute of Health Economicshttps://vimeo.com/album/5021382/video/258736790 Greetings from the Province of Alberta Mr. Justin RiemerADM, Innovation & Strategic Operations, Alberta Healthhttps://vimeo.com/album/5021382/video/257997522 13:15 – 14:35 Where Does the…
Speaker Biograpies Keynote Speakers Dr. Brian O’Rourke Dr. Brian O’Rourke is the President and Chief Executive Officer of CADTH. He joined CADTH in January of 2009 following a distinguished career as a Pharmacist and Health Service Executive with the Canadian military. With over 30 years of experience in health care, Brian actively positions CADTH as the leading source…
22 February 2018 Edmonton, Alberta On February 22nd, 2018 the Institute Health Economics (IHE), the Canadian Agency for Drugs & Technologies in Health (CADTH), and Alberta Health presented a forum: Doing the Right Thing ... Right: Evidence Informing Clinical Decision-Making. The purpose of this event was to provide a platform for shared learning and to showcase CADTH and Alberta…
To learn more about the Alberta Real World Evidence (RWE) Consortium, please visit www.AlbertaRWE.ca! Evidence that captures the observed impact of a process or technology on health outcomes and resource utilization outside of controlled clinical trials (real-world evidence or RWE) is highly valuable to technology developers, manufacturers, regulators, payers, clinicians, and…